CN101961406B - Medicament for treating muscle and bone diseases caused by chronic infectious arthritis - Google Patents
Medicament for treating muscle and bone diseases caused by chronic infectious arthritis Download PDFInfo
- Publication number
- CN101961406B CN101961406B CN2010105225728A CN201010522572A CN101961406B CN 101961406 B CN101961406 B CN 101961406B CN 2010105225728 A CN2010105225728 A CN 2010105225728A CN 201010522572 A CN201010522572 A CN 201010522572A CN 101961406 B CN101961406 B CN 101961406B
- Authority
- CN
- China
- Prior art keywords
- medicament
- bone diseases
- chronic infectious
- treating muscle
- infectious arthritis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention discloses a medicament for treating muscle and bone diseases causes by chronic infectious arthritis, which is prepared into capsules from the raw materials including pangolin scales, earthworm, scorpio, rhizoma corydalis, Ukraine snake, suberect spatholobus stem, common monkshood mother root, kusnezoff monkshood root, ramulus et uncus uncariae, diclofenac sodium sustained release tablets, metoclopramide, noded pit viper and centipede. The medicament of the invention has small active ingredient loss and remarkable treatment effect and has the characteristics of addressing both the symptoms and root causes, avoiding side effects, effectively treating muscle and bone diseases causes by chronic infectious arthritis, along with low cost and short treatment course. When the medicament is used for treating muscle and bone diseases, such as osteoproliferation, protrusion of lumbar vertebral disc, cervical spondylosis and scapulohumeral periarthritis, caused by chronic infectious arthritis in clinic, the effectiveness of the medicament is up to 90 percent.
Description
Technical field the invention belongs to technical field of pharmaceuticals, is specifically related to a kind of medicine of treating the muscle and joint disease that rheumatoid arthritis causes.
The background technology rheumatoid arthritis be a kind of be the chronic systemic autoimmune disease of characteristic with the articular synovitis.Synovitis is outbreak repeatedly lastingly, the destruction that can cause intraarticular cartilage and bone, and joint function disturbance, in addition maimed.The vasculitis pathological changes is involved each organ of whole body, so primary disease is called rheumatoid disease again.Rheumatoid arthritis is a kind of inflammatory autoimmune disease of chronic, general; The main whole body joint everywhere of invading is multiple, symmetry, chronic, hyperplastica synovitis, causes joint capsule and cartilage destruction, bone erosion then; Cause joint deformity, these are these sick characteristics.Can cause multiple muscles and bones diseases such as hyperosteogeny, prolapse of lumbar intervertebral disc, cervical vertebra, scapulohumeral periarthritis.Treatment of these diseases, mainly drug or surgical treatment, such as aspirin, non-steroidal anti-inflammatory drugs, better, its analgesic, antipyretic and anti-inflammatory effects are stronger; Japan imports left Teng moxibustion, Left Teng moxibustion in the online price is 450 yuan a course of treatment, rheumatoid disease very significant effect.But these medicines are Western medicine mostly, and side effect is big, expense is high, the course of treatment is long, and the operative treatment patient suffering is big.
The medicine of the muscle and joint disease that summary of the invention the purpose of this invention is to provide a kind of treating both the principal and secondary aspects of a disease, has no side effect, expense is low, the treatment rheumatoid arthritis of no pain causes solves prior art and has the technical problem that side effect is big, expense is high, the course of treatment is long, the operative treatment patient suffering is big.
Solution of the present invention is based on pathogeny and the understanding and the Therapeutic Principle of the muscle and joint disease that motherland's medical science causes rheumatoid arthritis; With reference to ancient, modern pharmacological research achievement, from motherland's medical treasure-house, filter out the muscle and joint disease that rheumatoid arthritis is caused and treat effective medicine.
Medicine of the present invention is processed by following raw material medicaments:
Squama Manis 30g, Pheretima 30g, Scorpio 15g, Rhizoma Corydalis 20g, Zaocys 20g, Caulis Spatholobi 20g, Radix Aconiti 20g, Radix Aconiti Kusnezoffii 20g, Ramulus Uncariae Cum Uncis 15g, 200 of YIERSONG, 300 of metoclopramide, 4 of Agkistrodons, 5 of Scolopendras; Above-mentioned each component mix homogeneously is ground to form the segmentation of 100 orders, incapsulate.
Every capsule explosive payload is 1g.
Medicine of the present invention is named and is " quick-acting muscles and bones relax ".
The clinical use result of medicine of the present invention " quick-acting muscles and bones are relaxed " shows that following advantage is arranged:
1, has rapid antiinflammatory, analgesic effect;
2, effective ingredient of the present invention scatters and disappears for a short time, and curative effect is high, has treating both the principal and secondary aspects of a disease, has no side effect, expense is low, short treating period, effective characteristics of muscle and joint disease that the treatment rheumatoid arthritis is caused.
For showing the curative effect of medicine of the present invention " quick-acting muscles and bones relax ", case is selected in the clinical observation of the present invention surplus ten year, and oral 3 times of every day, each 3～4, nearly 1000 examples of treatment patient, the state of an illness are clearly better to effectively, and total effective rate is 90%.
Model case is following:
1, Lee XX, the man, 45 years old, Clinical Laboratory was that rheumatoid arthritis causes the gonalgia and hypertrophy, with the present invention " quick-acting muscles and bones are relaxed ", treated 30 days transference cures.
2, public XX, the man, 50 years old, Clinical Laboratory was that rheumatoid arthritis causes prolapse of lumbar intervertebral disc, with the present invention " quick-acting muscles and bones are relaxed ", treated 40 days transference cures.
3, king XX, the man, 50 years old, Clinical Laboratory was that rheumatoid arthritis causes scapulohumeral periarthritis, with the present invention " quick-acting muscles and bones are relaxed ", treated 30 days transference cures.
4, king XX, the man, 55 years old, Clinical Laboratory was that rheumatoid arthritis causes prolapse of lumbar intervertebral disc.With the present invention " quick-acting muscles and bones are relaxed ", treat 60 days transference cures.
5, Song XX, the man, 55 years old, Clinical Laboratory was that rheumatoid arthritis causes arthralgia and prolapse of lumbar intervertebral disc.With the present invention " quick-acting muscles and bones are relaxed ", treat 60 days transference cures.
6, Liu XX, the man, 40 years old, Clinical Laboratory was that rheumatoid arthritis causes arthralgia and prolapse of lumbar intervertebral disc and bone matrix hyperplasia.With the present invention " quick-acting muscles and bones are relaxed ", treat 80 days transference cures.
The specific embodiment
Press following proportioning weighting raw materials:
Squama Manis 30g, Pheretima 30g, Scorpio 15g, Rhizoma Corydalis 20g, Zaocys 20g, Caulis Spatholobi 20g, Radix Aconiti 20g, Radix Aconiti Kusnezoffii 20g, Ramulus Uncariae Cum Uncis 15g, 200 of YIERSONG, 300 of metoclopramide, 4 of Agkistrodons, 5 of Scolopendras; Above-mentioned each component mix homogeneously is ground to form the segmentation of 100 orders, incapsulate, every capsule explosive payload is 1g.
Use medicine of the present invention " quick-acting muscles and bones are relaxed " points for attention: avoid: seafood.
Claims (1)
1. medicine of treating the muscle and joint disease that rheumatoid arthritis causes is characterized in that it is processed by following raw material medicaments: Squama Manis 30g, Pheretima 30g, Scorpio 15g, Rhizoma Corydalis 20g, Zaocys 20g, Caulis Spatholobi 20g, Radix Aconiti 20g, Radix Aconiti Kusnezoffii 20g, Ramulus Uncariae Cum Uncis 15g, 200 of YIERSONG, 300 of metoclopramide, 4 of Agkistrodons, 5 of Scolopendras; Above-mentioned each component mix homogeneously is ground to form 100 order fine powders, incapsulate.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2010105225728A CN101961406B (en) | 2010-10-28 | 2010-10-28 | Medicament for treating muscle and bone diseases caused by chronic infectious arthritis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2010105225728A CN101961406B (en) | 2010-10-28 | 2010-10-28 | Medicament for treating muscle and bone diseases caused by chronic infectious arthritis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101961406A CN101961406A (en) | 2011-02-02 |
| CN101961406B true CN101961406B (en) | 2012-05-23 |
Family
ID=43514580
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2010105225728A Expired - Fee Related CN101961406B (en) | 2010-10-28 | 2010-10-28 | Medicament for treating muscle and bone diseases caused by chronic infectious arthritis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101961406B (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103041362B (en) * | 2013-01-17 | 2014-04-30 | 广西东兴市创新特色医药科技发展有限公司 | Drug for treating rheumatism and rheumatoid and preparation method thereof |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1290551C (en) * | 2004-02-24 | 2006-12-20 | 司创 | A Chinese medicinal composition for invigorating kidney and strengthening bone |
| CN100586464C (en) * | 2004-03-30 | 2010-02-03 | 张家深 | Plaster of easing pain, removing swelling, promoting blood flow and removing blood stasis, activating the channels and removing rheumatism and preparation method |
| CN101327259B (en) * | 2008-07-29 | 2011-01-05 | 乔佐 | Medicament for treating protrusion of lumbar vertebral disc |
-
2010
- 2010-10-28 CN CN2010105225728A patent/CN101961406B/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN101961406A (en) | 2011-02-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102920984B (en) | Medicine for curing rheumatoid arthritis | |
| CN101579484B (en) | Traditional Chinese medicine preparation for treating rheumatic cold pain | |
| CN101797327B (en) | Chinese medicinal preparation for treating pain caused by orthopedic diseases | |
| CN102552693B (en) | Medicinal liquor for treating bone disease and its preparation method | |
| CN102258671B (en) | Plaster for treating gout and preparation method thereof | |
| CN100417401C (en) | Medicine for blood stanching, stasis transforming and bone joining | |
| CN103330806B (en) | Drug for treatment of rheumatoid arthritis | |
| CN103933129B (en) | Plaster for treating pain | |
| CN103054965B (en) | External analgesic plaster for treating arthralgia and preparation method of external analgesic plaster | |
| CN101961406B (en) | Medicament for treating muscle and bone diseases caused by chronic infectious arthritis | |
| CN108295128B (en) | Traditional Chinese medicine compound preparation for treating rheumatoid arthritis and preparation method thereof | |
| CN102885961B (en) | Medicine for treating rheumatic arthritis and rheumatoid arthritis and method for preparing medicine | |
| CN104546983A (en) | Primary and secondary plaster for treating rheumatism and preparation method thereof | |
| CN104107288A (en) | Sinew-relaxing collateral-activating pill | |
| Panda | Ayurveda Treatment Outcomes for Osteoarthritis | |
| CN102430096B (en) | Medicament for treating rheumatic or rheumatoid diseases | |
| CN101961467A (en) | Medicine for treating knee osteoarthritis and preparation method and application thereof | |
| CN101912570B (en) | Medicinal composition for treating rheumatism and preparation method thereof | |
| CN103585483A (en) | Traditional Chinese medicine composition for treating knee osteoarthritis and preparation method of same | |
| CN107469017A (en) | One kind chases after wind acesodyne capsule | |
| CN101361934B (en) | Traditional Chinese medicine preparation for treating arthritis and various osteonosus | |
| CN102949672A (en) | Medicine for treating pelvic inflammation | |
| CN102139087A (en) | Medicament for treating rheumatoid arthritis and preparation method thereof | |
| CN102416153B (en) | Medicament for treating rheumatic arthritis | |
| CN104069182A (en) | A pharmaceutical composition for treating osteoarthritis and a preparing method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| ASS | Succession or assignment of patent right |
Owner name: YAO ZHUANBIN Effective date: 20120214 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| C53 | Correction of patent for invention or patent application | ||
| CB03 | Change of inventor or designer information |
Inventor after: Li Guibin Inventor after: Yao Chuanbin Inventor after: Li Xiaolong Inventor after: Wang Yuezhang Inventor before: Li Guibin Inventor before: Li Xiaolong Inventor before: Wang Yuezhang |
|
| COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: LI GUIBIN LI XIAOLONG WANG YUEZHANG TO: LI GUIBIN YAO ZHUANBIN LI XIAOLONGWANG YUEZHANG |
|
| TA01 | Transfer of patent application right |
Effective date of registration: 20120214 Address after: 276200, Shandong, Linyi province Mengyin County wild town shop village Applicant after: Li Guibin Co-applicant after: Yao Chuanbin Address before: 276200, Shandong, Linyi province Mengyin County wild town shop village Applicant before: Li Guibin |
|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20120523 Termination date: 20121028 |